Carboplatin Paclitaxel in Ovarian Cancer
OncoPharm
00:00
Context of 2003 and Study Rationale
John Bazar explains why revisiting the 2003 carboplatin–paclitaxel study matters and sets up the clinical question.
Play episode from 00:33
Transcript
John Bazar explains why revisiting the 2003 carboplatin–paclitaxel study matters and sets up the clinical question.
